March 10, 2025 (Maple Hill Syndicate) Company insiders are ditching their own stock more than usual. An exception is oil and gas executives, some of whom are buying while their shares are depressed. To gauge insider sentiment, look at the ratio of buys to sells by top executives and large shareholders. According to Gurufocus.com, about 34% of insiders' transactions normally are buys. In February the figure was only 24%. Warning! GuruFocus has detected 4 Warning Sign with PANW. During the early stages of the pandemic in 2020, when stock prices dived, insiders stepped up to the plate and bought shares at an above-normal clip five months in a row. Insiders also bought a lot of stock in the late stages of the Great Recession in 2008. Sells normally exceed buys because top executives get some stock (often in the form of stock options) as part of their compensation. Lately, we've seen ten months in a row of below-normal buying. According to a screen I did on Gurufocus.com, chief executive officers at 197 companies have sold stock worth $1 million or more from February 1 through March 5. CEO Sales At Palo Alto Networks Inc. (NASDAQ:PANW), CEO Nikesh Arora sold more than $275 million of stock in February and March. Since June 2022, his share holding has fallen from about 2.9 million shares to about 1.1 million shares. His sales were under a plan that provides for selling at predetermined intervals or prices. At J.P Morgan Chase & Co. (NYSE:JPM), chairman Jamie Dimon was a buyer in 2007, 2009, 2012, and 2016. Since last year he's been a seller. In February he sold $233 million of stock, or more than 11% of his holding. His remaining shares are worth about $1.6 billion. At Tempus AI Inc. (NASDAQ:TEM), which went public less than a year ago, CEO Eric Lefkofsky cashed in more than $119 million in shares in February. That was about 8% of his holding. Bahram Akradi, the founder and CEO of Life Time Group Holdings Inc. (NYSE:LTH), sold 31% of his shares in late February, for proceeds of about $150 million. The company operates a chain of fitness centers. Akradi himself is a triathlete. Jeffrey Tangney, CEO of Doximity Inc. (NYSE:DOCS), sold about $75 million of his company's stock in February. He has about $135 million of Doximity shares left. The company operates a digital platform for medical professionals. When CEOs sell shares, it doesn't necessarily mean that they are bearish on the stock market or on their own companies' prospects. There are many reasons to sell, simple diversification being one. Still, when I see the number of CEOs who have sold recently, and the volume of their sales, it gives me an uneasy feeling. Story Continues Energy Buys In the oil and gas industry I see more hopeful signs. At Noble Corp. (NYSE:NE), for example, CEO Robert Eifler spent about $350,000 to add a bit to his holdings, which amount to about $31 million at current prices. Richard Barker, the chief financial officer, bought about $223,000 of Noble shares in February and has about $7 million in the stock. At Dorchester Minerals LP (NASDAQ:DMLP), which collects royalties on oil-and-gas properties in 28 states, CEO Bradley Ehrman spent about $100,000 on his partnership's shares in early March. He has about $4 million in it. And at Matador Resources Co. (NYSE:MTDR), where I've noted insider buying previously, CEO Joseph Foran made four purchases totaling about $632,000. That brings his holding to about $245 million. Oil and gas stocks are out of favor today, and I think they are oversold. I believe these three CEOs will be happy about their purchases a year hence. The Record This is the 73rd column I've written about insider purchases and sales. I can tabulate results for 63 columns all those written from 1999 through a year ago. Stocks that I said to avoid, even though insiders were buying, have under-performed the Standard & Poor's 500 Total Return Index by 24.3 percentage points. Stocks where I noted insider selling have done 2.3 percentage points worse than the index. Stocks I recommended based on insider buying have returned 9.1% -- not too bad, but 1.3 percentage points below the benchmark's average. Finally, there were some stocks where I noted insider buys, but made no comment or an ambiguous comment. These have beaten the S&P by 16.2 percentage points. Bear in mind that my column results are hypothetical and shouldn't be confused with results I obtain for clients. Also, past performance doesn't predict the future. Disclosure: I own J.P. Morgan shares personally and for most of my clients. John Dorfman is chairman of Dorfman Value Investments in Boston. His firm of clients may own or trade securities discussed in this column. He can be reached at [email protected]. This article first appeared on GuruFocus. View Comments
CEOs at 197 Companies Made Big Stock Sales Lately
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...